Meniscus prosthesis receives € 2.5 million EU grant
The European Commission grants € 2.5 million to ATRO Medical for the accelerated development of their artificial meniscus. The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain. Their ground-breaking innovation continues to attract international attention, paving the way towards full-scale healthcare implementation.
June 7th, 2022
The EIC Accelerator program is the most important instrument of the European Commission to support promising healthcare innovations. The program aims to develop and scale up game changing innovations. The EIC Accelerator grant provides access to an investment by the EIC Fund, coordinated by the European Commission and particularly used to bridge the funding gap between market entry and scale up.
The € 2.5 million grant will be spent on accelerating pre-clinical testing of the meniscus prostheses, on health economic analyses and international clinical studies. All efforts combined will fast-track the implementation of this Dutch healthcare innovation. ATRO Medical is the first company worldwide to have solutions for both the inner and outer meniscus close to the clinical stage.
Thousands of patients suffering from chronic knee pain are waiting for these solutions. Their meniscus has been removed as a result of an earlier trauma and they have developed the so-called post-meniscectomy pain syndrome. Orthopedic surgeon and Chief Medical Officer Dr. Tony van Tienen explains, “I see many patients with chronic knee pain in my clinical practice. Most of them are too young for a total knee replacement. However, they should be able to go to work, go shopping or simply walk their dog without constantly being bothered by an aching knee. Our artificial meniscus aims to relieve that pain. Pain free mobility, that is what we strive for.”
ATRO Medical has already received several international recognitions for their thought-leading work like FDA breakthrough device designation, Eurostars funding and the Johnson & Johnson Quickfire award. In the next few years, the company will leverage these endorsements and funds to significantly expand their clinical evidence and achieve market registration. Together with partners like the Dutch Arthritis Society, the Orthopaedic Research Laboratory and international clinics such as the Sint Maartenskliniek, Mayo Clinic and Sporthopaedicum Berlin they are confident to succeed.
Share this article
Do you want to read more?
View related articles here
Artimis: New name for our artificial meniscus
Patients
Artimis®: the new name for the world’s first artificial meniscus
ATRO Medical launches unique meniscus research
Patients
As the first company worldwide, ATRO Medical will start a clinical trial on a lateral artificial meniscus. For the first time ever, an absent meniscus in the outer part of the knee will be replaced by an artificial meniscus, the Artimis® Meniscus Prosthesis. The study will be conducted at the Radboud University Medical Center in Nijmegen.
AIR2 study information
Patients
This clinical study is initiated in October 2021 to enroll 14 patients at select medical centers in the Netherlands. The study is full and can no longer accept new participants. The clinical study is approved by the Dutch government (Dutch Health and Youth Care Inspectorate) and Medical Research Ethics Committee.
Radboudumc and ATRO Medical start research on AI-generated artificial meniscus.
Professionals
The Orthopaedic Research Laboratory (ORL) of Radboudumc starts a new project with ATRO Medical: 3D-Printed PCU meniscus Prosthesis (3PPP). 3PPP combines the latest developments in sports medicine with the strength of AI. The durable meniscus prosthesis of ATRO Medical will be designed in 3D based on artificial intelligence, developed by the Orthopaedic Research Lab. Thanks to this technology, a scan of the healthy meniscus in one leg can be used to create a meniscus solution for the affected leg. In this way, the side with a lacking meniscus causing severe knee pain can receive a new shock absorber, molded to the individual patient.
Dutch meniscus prosthesis receives FDA Breakthrough Device Designation
Patients
Dutch medical innovations are rarely granted the Breakthrough Designation by the FDA. Startup ATRO Medical from Nijmegen is the new kid on the block in orthopedics. This week their Trammpolin® meniscus prosthesis (nowadays known as Artimis®), designed to treat chronic knee pain, received the Breakthrough Device Designation from the FDA. The designation demonstrates the innovation potential of this implant and expedites US market access by receiving a priority treatment at the FDA.
EUROSTARS grants funding for first lateral meniscus prosthesis
Professionals
An international consortium led by the Dutch med-tech startup ATRO Medical receives over € 800,000 EUROSTARS funding to address an unmet need for Knee Osteoarthritis patients. These patients often suffer from cartilage degradation related to a dysfunctional meniscus. Based on previous research, the consortium will develop a durable meniscus prosthesis for the outer knee compartment to relief pain and restore mobility. This would change the life of thousands of osteoarthritis patients.
ATRO Medical Named Awardee in the Johnson & Johnson Innovation Veterans Lead QuickFire Challenge
Professionals
Yess!! ATRO Medical has been named an Awardee in the Veterans Lead QuickFire Challenge organized by Johnson & Johnson Innovation!
The Dutch Arthritis Society supports further development of the meniscus prosthesis of ATRO Medical
Patients
Orthopedic startup ATRO Medical enters a partnership together with the Dutch Arthritis Society for further development of the artificial meniscus. The Dutch startup works on a meniscus prosthesis for people with knee arthritis. The Dutch Arthritis Society supports these developments and shares its experience as patient expert in the field of arthritis.
Meniscus prosthesis receives € 2.5 million EU grant
Professionals
The European Commission grants € 2.5 million to ATRO Medical for the accelerated development of their artificial meniscus. The Dutch startup works on the first anatomical meniscus prostheses for patients with chronic knee pain. Their ground-breaking innovation continues to attract international attention, paving the way towards full-scale healthcare implementation.
ATRO Medical B.V.
We are an innovative medical device company that was was founded in 2016. The lead product is the Artimis® meniscus prosthesis.
Contact details
Novio Tech Campus
Transistorweg 5, 6534 AT Nijmegen (Headquarters)
Liessentstraat 9a, 5405 AH Uden (Registered office)
info@atromedical.com
Navigation
Newsletter
Stay informed of the latest news and development regarding Artimis®!
